SONNET BIOTHERAPEUTICS HOLDINGS, INC.: revenue

What this measure means

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Exact concept: us-gaap:Revenues. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2010-01-01 to 2018-12-31. The SEC response was captured on 2026-09-21.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Selected filing history

Related financial histories

• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: total assets
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: total liabilities
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: stockholders equity
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: cash and cash equivalents
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: net income or loss
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: operating cash flow
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: capital expenditure payments
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: contract revenue excluding tax
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: financing cash flow
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: investing cash flow
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: retained earnings or deficit
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: basic weighted-average shares
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: diluted weighted-average shares
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: basic earnings per share
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: diluted earnings per share
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: income tax expense or benefit
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: net property, plant and equipment
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: share-based compensation expense
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: operating income or loss
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: current assets
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: interest expense
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: current liabilities
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: current accounts payable
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: goodwill carrying amount
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: net finite-lived intangible assets
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: net current accounts receivable
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: operating expenses
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: net inventory
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: research and development expense
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: common shares outstanding
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: cash including restricted cash
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: additional paid-in capital
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: accumulated other comprehensive income or loss
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: total equity including noncontrolling interests
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: operating lease right-of-use asset
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: operating lease liability
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: long-term debt
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: gross property, plant and equipment
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: accumulated depreciation on property, plant and equipment
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: net intangible assets excluding goodwill
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: other noncurrent assets
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: other noncurrent liabilities
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: accrued current liabilities
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: prepaid expenses and other current assets
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: net deferred tax assets
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: pre-tax income or loss from continuing operations
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: profit or loss including noncontrolling interests
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: comprehensive income or loss
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: net income available to common stockholders
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: general and administrative expense
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: depreciation expense
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: depreciation, depletion and amortization
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: amortization of intangible assets
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: nonoperating income or expense
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: interest paid, net
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: income taxes paid, net
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: proceeds from issuing common stock
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: operating lease payments
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: change in accounts receivable
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: change in inventories
• SONNET BIOTHERAPEUTICS HOLDINGS, INC.: change in accounts payable

Inspect the source

Entity

SONNET BIOTHERAPEUTICS HOLDINGS, INC. / CIK 0001106838

Captured

2026-09-21T17:18:22.439Z

SEC response SHA-256

3f4ed3e191d870392f866d0b7de79fd0378ba4f8669f59d59de1a0b18cd3dce4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001106838.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))